- Home
- AARD vs CIA Comparison
AARD vs CIA Comparison
Compare AARD & CIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AARD | CIA |
|---|---|---|
| Founded | 2017 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Life Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 281.1M | 251.0M |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | AARD | CIA |
|---|---|---|
| Price | $5.07 | $4.67 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $19.63 | N/A |
| AVG Volume (30 Days) | ★ 375.2K | 119.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $245,001,000.00 |
| Revenue This Year | N/A | $3.65 |
| Revenue Next Year | N/A | $3.51 |
| P/E Ratio | ★ N/A | $28.23 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.74 | $2.90 |
| 52 Week High | $17.94 | $6.40 |
Technical Indicators
Market Signals| Indicator | AARD | CIA |
|---|---|---|
| Relative Strength Index (RSI) | 22.62 | 30.40 |
| Support Level | $4.74 | $3.34 |
| Resistance Level | $15.88 | $5.44 |
| Average True Range (ATR) | 0.54 | 0.37 |
| MACD | -0.33 | -0.10 |
| Stochastic Oscillator | 4.23 | 9.57 |
Price Performance
Historical ComparisonAbout AARD Aardvark Therapeutics Inc.
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
About CIA Citizens Inc. ($1.00 Par)
Citizens Inc is an insurance holding company serving the life insurance needs of individuals in the United States. The company provides insurance benefits to residents in thirty two U.S. states and more than seventy countries through its insurance subsidiaries. The company operates in two business segments namely the Life Insurance segment and the Home Service Insurance segment. The company majority generates revenues from Life Insurance segment. Company operates in USA, Columbia, Taiwan, Venezuela, Ecuador, Argentina, and Others.